Moreover, several of the targets previously discussed with other solid tumors, such as HER2, EGFR, ROR1, MSLN, PD-L1, MUC1, and CEA, are also currently being studied for CAR-T cell treatment for lung cancer. This evidence concerns the gene ERBB2 and lung cancer.